EUVIMEDEUVIMED entdecken
Crossref

Impact of Medium Cut‐Off Dialysis Membranes on Outcomes in COVID ‐19 Patients With Acute Kidney Injury

Omer Faruk Akcay iD, Handenur Koc Kanik, Arif Burak Kanik, Taha Enes Cetin, Saliha Yildirim, Haci Hasan Yeter, Ulver Derici

Therapeutic Apheresis and Dialysis · 2026

DOI: 10.1111/1744-9987.70088 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Therapeutic Apheresis and Dialysis, 2026. Verfasst von Omer Faruk Akcay und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Faculty of Medicine, Gazi University, Ankara, Türkiye. Hauptthemen laut MEDLINE: Acute Kidney Injury, COVID-19, Renal Dialysis, Membranes, Artificial. Die Arbeit nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has led to significant morbidity and mortality worldwide, with acute kidney injury (AKI) emerging as a significant non‐pulmonary complication of COVID‐19. This study aimed to evaluate the effect of hemodialysis (HD) membrane type on the outcomes of COVID‐19 patients with AKI requiring dialysis.

Methods

A retrospective analysis was conducted on 82 COVID‐19 patients with AKI who required HD between January 2020 and January 2022. Patients were categorized based on the type of dialysis membrane used as medium cut‐off (MCO) versus low‐flux (LF). Demographic data, clinical characteristics, laboratory findings, and hospital outcomes, including 28‐day mortality, were analyzed.

Results

The mean age of the study population was 69.7 ± 11.6 years, with 45% being female. The median time to HD initiation was shorter in the LF group ( p < 0.001). Although ICU admission rates were similar between the groups, the 28‐day mortality rate was significantly lower in the MCO group ( p = 0.03). Multivariate analysis identified ICU admission as an independent risk factor for mortality while using MCO membranes, associated with a reduced mortality risk (OR: 0.344, p = 0.03). MCO membrane was significantly associated with a higher 28‐day survival rate by Kaplan–Meier curve analysis with log‐rank test (56.8% vs. 33.3%, p = 0.001).

Conclusions

The findings suggest that using MCO membranes in HD may improve survival outcomes in COVID‐19 patients with AKI. Further prospective studies are needed to validate these results and elucidate the potential anti‐inflammatory benefits of MCO membranes in this patient population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Kidney InjuryCOVID-19Renal DialysisMembranes, ArtificialHumansFemaleMaleRetrospective StudiesAgedMiddle AgedAged, 80 and overRisk FactorsIntensive Care UnitsTreatment Outcome

Stichwörter der Autor:innen

COVID‐19acute kidney injurydialysis membranehemodialysismortality

Substanzen

Membranes, Artificial

Autor:innen und Institutionen

  • Department of Nephrology, Faculty of Medicine, Gazi University, Ankara, Türkiye.
  • Department of Internal Medicine, Iskilip Atif Hoca State Hospital, Corum, Türkiye.
  • Department of Nephrology, Sincan Training and Research Hospital, Ankara, Türkiye.
  • Department of Nephrology, Faculty of Medicine, Hacettepe University, Ankara, Türkiye.

ORCID-Profile: Omer Faruk Akcay

Zitieren

APA

Akcay, O. F., Kanik, H. K., Kanik, A. B., Cetin, T. E., Yildirim, S., Yeter, H. H., & Derici, U. (2026). Impact of Medium Cut‐Off Dialysis Membranes on Outcomes in COVID ‐19 Patients With Acute Kidney Injury. Therapeutic Apheresis and Dialysis. https://doi.org/10.1111/1744-9987.70088

Vancouver

Akcay OF, Kanik HK, Kanik AB, Cetin TE, Yildirim S, Yeter HH, et al. Impact of Medium Cut‐Off Dialysis Membranes on Outcomes in COVID ‐19 Patients With Acute Kidney Injury. Therapeutic Apheresis and Dialysis. 2026. doi:10.1111/1744-9987.70088

BibTeX
@article{Akcay2026,
  author = {Akcay, Omer Faruk and Kanik, Handenur Koc and Kanik, Arif Burak and Cetin, Taha Enes and Yildirim, Saliha and Yeter, Haci Hasan and Derici, Ulver},
  title = {Impact of Medium Cut‐Off Dialysis Membranes on Outcomes in COVID ‐19 Patients With Acute Kidney Injury},
  journal = {Therapeutic Apheresis and Dialysis},
  year = {2026},
  doi = {10.1111/1744-9987.70088}
}
Kostenlos starten →